[topsearch__bar__shortcode]

January 27, 2023

Applied Therapeutics (APLT) Stock Going In For The Kill

Applied Therapeutics Inc. (NASDAQ: APLT) is a biotech company with a focus on galactosemia, diabetes, and cardiovascular conditions. Its lead candidate is AT-007 which will be at the front of galactosemia conditions in young children. With its market capitalization of $54 million, APLT is a small company, but one that holds immense potential, going forward. […]

Applied Therapeutics (APLT) Stock Going In For The Kill Read More »

GeoVax Labs (GOVX) Stock Makes Stellar Gains

GeoVax Labs Inc. (NASDAQ: GOVX) is a biotechnology company that specializes in developing and commercializing treatments for various cancers and viral conditions. Many describe GeoVax as being at the forefront of the global battle against several deadly viruses, including the Zika condition. It has recently been making terrific strides in the market, due to some

GeoVax Labs (GOVX) Stock Makes Stellar Gains Read More »

COMSovereign (COMS) Stock Hits The Sweet Spot

COMSovereign Holding Corp. (NASDAQ: COMS) is a telecom solutions company offering next-gen technological tools to mobile device carriers, network operators, enterprises, and government agencies. Its stock price has been seeing a remarkable surge in the last few days, owing to an announcement made by the management of the company. COMSovereign Goes After Naked Short Selling

COMSovereign (COMS) Stock Hits The Sweet Spot Read More »

Intel Corporation’s (INTC) Pressures Keep Mounting Up

Intel Corporation (NASDAQ: INTC) has been facing the brunt of the market’s wrath in recent days after its price has been falling lower with each dip. This negative sentiment that surrounds INTC stock continues to drive ahead by several financial and fundamental indicators that place the company’s wider sustainability under question. The Intel Earnings Miss

Intel Corporation’s (INTC) Pressures Keep Mounting Up Read More »

ContraFect Corporation (CFRX) Suffers Falling Market Confidence

ContraFect Corporation (NASDAQ: CFRX) is a clinical-stage biotech player which focuses primarily on antibody-based treatments and several strains of protein material as therapy. CFRX stock continues to find itself facing a series of difficult challenges, as hope becomes increasingly thin. CFRX Takes a Hit Amid News of Potential Delisting ContraFect Corporation (CFRX) saw its stock

ContraFect Corporation (CFRX) Suffers Falling Market Confidence Read More »

BuzzFeed Inc. (BZFD) Becomes Latest To Embrace AI Possibilities

BuzzFeed Inc. (NASDAQ: BZFD) has been on an epic rise as of late, climbing from $0.93 to $2.60, in a matter of just a few days. This sudden bullish momentum, that BZFD finds itself present within, points to a radical opportunity the content company has just captured. BuzzFeed to enter AI spaces There is a

BuzzFeed Inc. (BZFD) Becomes Latest To Embrace AI Possibilities Read More »